3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
2
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Breast
2
Thoracic
1
Genitourinary
1
Dermatologic
1
Conditions
Lung Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neurofibromatoses
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hydrocephalus
1
Headache
1
Gallbladder Neoplasms
1
Female Breast Carcinoma
1
Epilepsy
1
Disease Progression
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Edema
1
Abdominal Neoplasms
1
Interventions
Propofol
3
Oxaliplatin
3
Morphine
3
Fentanyl
3
Sevoflurane
2
Ropivacaine
2
Fluorouracil
2
Capecitabine
2
Bupivacaine
2
Bevacizumab
2
Acetaminophen
2
polyethylene glycol 3350
1
oxycodone-acetaminophen
1
gatorade
1
fish oil triglycerides
1
Vitamin D
1
Tranexamic Acid
1
Tramadol
1
Tegafur
1
Sodium Chloride
1
Simethicone
1
Saline Solution
1
Rivaroxaban
1
Polyethylene Glycols
1
Pirinitramide
1
Panitumumab
1
Orphenadrine
1
Neuroleptanalgesia
1
Midazolam
1
Methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Colonic Neoplasms
×
Sevoflurane
×
Clear all
NCT01975064
2022-12-14
CAN
Uppsala University
Phase 4
Completed
5,774 enrolled
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled